Industry insiders predict that with the continuous advancement of national policies in recent years, the stem cell industry will usher in a period of rapid growth. In the next 5 to 10 years, the "regeneration" of body tissues and organs will gradually become a reality and, like smartphones changing the public's lifestyle, set off a wave of innovation in the medical field.
Researchers in lab coats moving back and forth, various preparations in test tubes, smoking freezer boxes, chemical instruments with multiple intertwined lines... this is as if one were placed in a science fiction movie scene,and the "protagonist" running through the entire laboratory process is the current domestic and international medical hotspot "stem cells."
Stem cells are a type of multipotent cell with self-renewing and self-replicating capabilities. Stem cells can be divided into embryonic stem cells and adult stem cells. According to different differentiation potentials, they can be classified into totipotent stem cells, pluripotent stem cells, and unipotent stem cells. They have characteristics such as multi-directional differentiation potential and unlimited division and proliferation.
Stem cell therapy refers to the manipulation of stem cells in vitro, including in vitro proliferation, directed induction, transdifferentiation, gene modification, and tissue formation, to promote the repair of diseased, dysfunctional, or damaged tissues.
Data source: Clinicaltrials.gov
Stem cell research has been one of the most eye-catching hotspots in the fields of medicine and biology since the 1990s. In 1999, the American journal Science rated stem cell research as the top of the 10 most important scientific research fields of the 21st century. At present, research on stem cells and regenerative medicine has become the most eye-catching field in natural science. The increasing perfection of its theories and the rapid development of its technologies will surely produce epoch-making results in fields such as disease treatment and biomedicine, and represent a major revolution in traditional medical methods and medical concepts.
According to data from Clinicaltrials.gov, the clinical research registration system managed by the U.S. National Institutes of Health,as of June 1, 2022, a total of 6,197 stem cell clinical research projects had been registered worldwide,involving hundreds of diseases such as diabetes, osteoarthritis, stroke, Parkinson's disease and spinal cord injury, blood system diseases, nervous system diseases, limb ischemic diseases, cardiovascular and cerebrovascular diseases, endocrine system diseases, surgical diseases, skin diseases, tumors, and the immune system.
It is an indisputable fact that stem cell therapy has great potential for treating diseases, which indicates that cell therapy has entered a period of rapid development! Therefore, the quality of cell preparations and the standardization of production management are attracting increasing attention from the industry, including the R&D and production of vaccines and biopharmaceuticals,and in particular, the demand for higher cleanliness levels of upstream consumables is becoming even more urgent!
CellPro Biology
provides you with overall laboratory solutions
CellPro Biology is committed to providing global customers with high-quality consumables and customized services in molecular diagnostics, cell culture, immunotherapy, and other aspects. It has now mastered a number of key core technologies and advanced processes related to the field of biological laboratory consumables, has built a 10,000㎡ Class 100,000 clean production workshop, preferably uses high-quality raw materials that meet USP CLASS VI standards, and strictly implements and produces in accordance with GMP standards and the ISO 13485 and ISO 9001 quality management systems. It can provide cell culture consumables with higher cleanliness levels for stem cell therapy, and the products have good transparency, are non-pyrogenic, free of DNase/RNase, and non-cytotoxic, and can meet the needs of cell and tissue culture from single cells to large-scale culture.
As a leading enterprise in the upstream of the stem cell industry chain, CellPro Biology strives to contribute to the development of stem cell therapy and the Chinese Dream of health.As clinical research on stem cell therapy continues to make breakthroughs, more patients will benefit in the future.






Back to list



